Telo Genomics Financials

Telo Genomics Stock Summary

Telo Genomics competes with Grey Cloak. Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. Telo Genomics Corp. was incorporated in 2014 and is headquartered in Toronto, Canada. TELO GENOMICS is traded on OTC Exchange in the United States.

Telo Genomics Key Financial Ratios

There are many critical financial ratios that Telo Genomics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Telo Genomics Corp reports annually and quarterly.

Telo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Telo Genomics's current stock value. Our valuation model uses many indicators to compare Telo Genomics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Telo Genomics competition to find correlations between indicators driving Telo Genomics's intrinsic value. More Info.Telo Genomics Corp is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Telo Genomics' earnings, one of the primary drivers of an investment's value.

Telo Genomics Corp Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Telo Genomics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Telo Genomics Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Telo Genomics Corp based on widely used predictive technical indicators. In general, we focus on analyzing Telo OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Telo Genomics's daily price indicators and compare them against related drivers.

When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.